Skip to content

A randomized controlled clinical study of Shi's manipulation lysis in the treatment of lumbar disc herniation

A randomized controlled clinical study of Shi's manipulation lysis in the treatment of lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056790
Enrollment
Unknown
Registered
2022-02-17
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

Experimental group:Shi's manipulation lysis
The control group:lumbar ozone ablation

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 20-65 years; 2. In line with the diagnostic criteria of lumbar disc herniation (the 4th edition);3.To be able to understand the possible accidents and risks in the process of anesthesia and post-anesthesia Shi's manipulation release, and who voluntarily participate in this study and sign the "informed consent".

Exclusion criteria

Exclusion criteria: (1) Patients with skin damage, ulceration or skin diseases, patients with hyperthyroidism, G6-PD deficiency and blood diseases with bleeding tendency; (2) Imaging findings showed that the nucleus pulposus tissue prolapse into or free in the spinal canal, combined with spinal stenosis, lateral crypt stenosis, disc herniation with calcification, severe spinal trauma history; (3) Patients with spinal tumor and spinal tuberculosis; (4) Patients with cardiovascular, cerebrovascular, hematopoietic, digestive system and other serious diseases or mental illness; (5) Pregnant and lactating women; (6) patients with severe impairment of heart, liver and kidney function; (7) Other autoimmune diseases, allergic diseases, acute and chronic infections; (8) Those who are unwilling to join the experiment; (9) currently participating in other clinical trials; (10) Other circumstances considered inappropriate by the researcher to participate in the study;

Design outcomes

Primary

MeasureTime frame
oswestry disability index;

Secondary

MeasureTime frame
visual analogus scale;the MOS item short from health survey;

Countries

China

Contacts

Public ContactWang Xiang
w8X@163.com+86 13816985219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026